SPRO -  Spero Therapeutics

-

$undefined

N/A

(N/A)

Spero Therapeutics NASDAQ:SPRO Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug-resistant (MDR) bacterial infections and rare diseases.

Location: 675 Massachusetts Ave Ste 14, Massachusetts, 02139-3309, US | Website: sperotherapeutics.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-8.053M

Cash

52.89M

Avg Qtr Burn

-5.861M

Short % of Float

1.91%

Insider Ownership

23.86%

Institutional Own.

24.23%

Qtr Updated

12/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.